| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 16,466 | 19,862 |
| Depreciation and amortization | 149,912 | 99,110 |
| Noncash lease expense | 13,739 | 9,308 |
| Stock compensation | 41,879 | 26,636 |
| (loss) gain on disposal of property and equipment | -3,211 | -1,753 |
| Debt issuance costs amortization | 5,112 | 3,482 |
| Change in fair value of contingent earn-out | 0 | 0 |
| Equity in earnings of unconsolidated affiliates | 1,296 | 2,837 |
| Disposal group, not discontinued operation, gain (loss) on disposal | 44,792 | 41,823 |
| Other | -18,217 | -8,037 |
| Accounts receivable | -3,943 | -16,691 |
| Inventories | 36,213 | 29,213 |
| Prepaid expenses and other current assets | 4,721 | 9,208 |
| Other assets | 7,149 | 5,682 |
| Accounts payable | 23,328 | 14,382 |
| Accrued liabilities | -28,887 | -19,835 |
| Income taxes, including excess tax benefits and deferred income taxes | -33,501 | -28,125 |
| Net cash provided by operating activities | 119,248 | 62,538 |
| Purchases of property, plant and equipment | 63,397 | 34,317 |
| Proceeds from sales of business, affiliate and productive assets | 211,185 | 209,464 |
| Proceeds from sale of asset | 42 | 42 |
| Intangible assets additions | 7,210 | 4,541 |
| Proceeds from sale of investment securities | 0 | 0 |
| Net cash used in investing activities | 140,620 | 170,648 |
| Repayments of long-term debt | 272,750 | 247,750 |
| Proceeds from exercise of stock options | 5,972 | 5,972 |
| Payments on finance leases | 1,543 | 885 |
| Payment for contingent consideration liability, financing activities | 0 | 0 |
| Payment, tax withholding, share-based payment arrangement | 8,719 | 8,688 |
| Net cash used in by financing activities | -277,040 | -251,351 |
| Effect of exchange rate on cash, cash equivalent, restricted cash, and restricted cash equivalent, continuing operation | 8,338 | 9,624 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect | -8,834 | -8,541 |
| Cash and cash equivalents at beginning of period | 308,566 | - |
| Cash and cash equivalents at end of period | 299,732 | - |
ICU MEDICAL INC DE (ICUI)
ICU MEDICAL INC DE (ICUI)